EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Apparently Resistant Hypertension in Polish Hemodialyzed Population: Prevalence and Risk Factors

Bartosz Symonides, Jacek Lewandowski iD, Wojciech Marcinkowski, Jacek Zawierucha iD, Tomasz Prystacki, Jolanta Małyszko iD

Journal of Clinical Medicine · 20.08.2023 · 12 (16) · 5407

DOI: 10.3390/jcm12165407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.08.2023. Verfasst von Bartosz Symonides und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim of this study was to assess the prevalence, characteristics, and determinants of apparent treatment-resistant hypertension (aTRH) in an unselected large population of patients with end-stage kidney disease (ESKD) treated with hemodialysis (HD) throughout the country.

Methods

A database of 5879 patients (mean age 65.2 ± 14.2 years, 60% of males receiving hemodialysis) was obtained from the biggest provider of hemodialysis in the country. Hypertension and aTRH were defined using pre- or/and post-dialysis BP values. Patients with and without aTRH (non-aTRH) were compared.

Results

Using pre- and post-dialysis criteria, hypertension was diagnosed in 90.7% and 89.1% of subjects, respectively. According to pre- and post-dialysis blood pressure criteria, aTRH incidences were 40.9% and 38.4%, respectively. The hypertensive patients with aTRH versus non-aTRH were younger, had a higher rate of cardiovascular disease, lower dialysis vintage, shorter time on dialysis, higher eKt/V, higher ultrafiltration, higher pre- and post-dialysis BP and HR, and higher use of antihypertensive drugs. Factors that increase the risk of aTRH according to both pre- and post-dialysis BP criteria were age—OR 0.99 [0.98–0.99] and 0.99 [0.98–0.99], the history of CVD 1.26 [1.08–1.46] and 1.30 [1.12–1.51], and diabetes 1.26 [1.08–1.47] and 1.28 [1.09–1.49], adjusted OR with 95% CI.

Conclusions

In the real-life world, as much as 40% of HD patients may have aTRH. In ESKD HD patients, aTRH seems to be multifactorial, influenced by patient-related rather than dialysis-related factors. Various definitions of aTRH preclude easy comparisons between studies.

Schlagwörter

Stichwörter der Autor:innen

apparent treatment-resistant hypertensionend-stage renal diseasehemodialysishypertensionresistant hypertension

Autor:innen und Institutionen

  • Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, 02-091 Warsaw, Poland.
  • Fresenius Medical Care, 60-118 Poznań, Poland.
  • Department of Nephrology, Dialysis and Internal Diseases, Medical University of Warsaw, 02-097 Warsaw, Poland.

ORCID-Profile: Jacek Lewandowski, Jacek Zawierucha, Jolanta Małyszko

Zitieren

APA

Symonides, B., Lewandowski, J., Marcinkowski, W., Zawierucha, J., Prystacki, T., & Małyszko, J. (2023). Apparently Resistant Hypertension in Polish Hemodialyzed Population: Prevalence and Risk Factors. Journal of Clinical Medicine, 12(16), 5407. https://doi.org/10.3390/jcm12165407

Vancouver

Symonides B, Lewandowski J, Marcinkowski W, Zawierucha J, Prystacki T, Małyszko J. Apparently Resistant Hypertension in Polish Hemodialyzed Population: Prevalence and Risk Factors. Journal of Clinical Medicine. 2023;12(16):5407. doi:10.3390/jcm12165407

BibTeX
@article{Symonides2023,
  author = {Symonides, Bartosz and Lewandowski, Jacek and Marcinkowski, Wojciech and Zawierucha, Jacek and Prystacki, Tomasz and Małyszko, Jolanta},
  title = {Apparently Resistant Hypertension in Polish Hemodialyzed Population: Prevalence and Risk Factors},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {16},
  pages = {5407},
  doi = {10.3390/jcm12165407}
}
Kostenlos starten →